137 related articles for article (PubMed ID: 31399647)
21. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
22. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis by L-NMMA, via FKHRL1/ROCK pathway in human gastric cancer cells.
Wang YZ; Feng ZQ
Biomed Environ Sci; 2006 Aug; 19(4):285-91. PubMed ID: 17044646
[TBL] [Abstract][Full Text] [Related]
24. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells.
Lee CW; Lin CC; Lin WN; Liang KC; Luo SF; Wu CB; Wang SW; Yang CM
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L799-812. PubMed ID: 17158602
[TBL] [Abstract][Full Text] [Related]
26. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
27. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
28. FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation.
Yang F; Xu J; Li H; Tan M; Xiong X; Sun Y
Nat Commun; 2019 Mar; 10(1):1382. PubMed ID: 30918250
[TBL] [Abstract][Full Text] [Related]
29. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
30. HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation.
Bollaert E; Johanns M; Herinckx G; de Rocca Serra A; Vandewalle VA; Havelange V; Rider MH; Vertommen D; Demoulin JB
Cell Signal; 2018 Apr; 44():158-170. PubMed ID: 29355710
[TBL] [Abstract][Full Text] [Related]
31. ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer.
Li Y; Yang Q; Guan H; Shi B; Ji M; Hou P
Cancer Res; 2018 Sep; 78(18):5216-5228. PubMed ID: 29997231
[TBL] [Abstract][Full Text] [Related]
32. Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.
Lee JY; Jang KS; Shin DH; Oh MY; Kim HJ; Kim Y; Kong G
Cancer Res; 2008 Jun; 68(11):4201-9. PubMed ID: 18519679
[TBL] [Abstract][Full Text] [Related]
33. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
[TBL] [Abstract][Full Text] [Related]
34. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
35. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.
Lee JY; Kang MB; Jang SH; Qian T; Kim HJ; Kim CH; Kim Y; Kong G
Oncogene; 2009 Feb; 28(6):824-31. PubMed ID: 19079342
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
37. Suppression of Akt-mediated HDAC3 expression and CDK2 T39 phosphorylation by a bichalcone analog contributes to S phase retardation of cancer cells.
Hung KC; Lin ML; Hsu SW; Lee CC; Huang RY; Wu TS; Chen SS
Eur J Pharmacol; 2018 Jun; 829():141-150. PubMed ID: 29665367
[TBL] [Abstract][Full Text] [Related]
38. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.
Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y
Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]